These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 30285835
1. Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation. Armstrong-Buisseret L, Mitchell E, Hepburn T, Duley L, Thornton JG, Roberts TE, Storey C, Smyth R, Heazell AEP. Trials; 2018 Oct 01; 19(1):531. PubMed ID: 30285835 [Abstract] [Full Text] [Related]
4. The CErebro Placental RAtio as indicator for delivery following perception of reduced fetal movements, protocol for an international cluster randomised clinical trial; the CEPRA study. Damhuis SE, Ganzevoort W, Duijnhoven RG, Groen H, Kumar S, Heazell AEP, Khalil A, Gordijn SJ. BMC Pregnancy Childbirth; 2021 Apr 09; 21(1):285. PubMed ID: 33836690 [Abstract] [Full Text] [Related]
5. Use of biochemical tests of placental function for improving pregnancy outcome. Heazell AE, Whitworth M, Duley L, Thornton JG. Cochrane Database Syst Rev; 2015 Nov 25; 2015(11):CD011202. PubMed ID: 26602956 [Abstract] [Full Text] [Related]
12. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes. Stock SJ, Bricker L, Norman JE, West HM. Cochrane Database Syst Rev; 2016 Jul 12; 7(7):CD008968. PubMed ID: 27404120 [Abstract] [Full Text] [Related]
13. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, Shennan AH, Chappell LC, PARROT trial group. Lancet; 2019 May 04; 393(10183):1807-1818. PubMed ID: 30948284 [Abstract] [Full Text] [Related]
14. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies. Bowe S, Mitlid-Mork B, Georgieva A, Gran JM, Redman CWG, Staff AC, Sugulle M. Acta Obstet Gynecol Scand; 2021 Oct 04; 100(10):1893-1901. PubMed ID: 34212381 [Abstract] [Full Text] [Related]
15. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor. Fiolna M, Machuca M, Karampitsakos T, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2019 Nov 04; 54(5):604-608. PubMed ID: 31444934 [Abstract] [Full Text] [Related]
16. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2). Hurrell A, Sparkes J, Duhig K, Seed PT, Myers J, Battersby C, Clark K, Green M, Hunter RM, Shennan AH, Chappell LC, Webster L. Trials; 2022 Sep 02; 23(1):722. PubMed ID: 36056408 [Abstract] [Full Text] [Related]
17. Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes. Sherrell H, Dunn L, Clifton V, Kumar S. Eur J Obstet Gynecol Reprod Biol; 2018 Jun 02; 225():26-34. PubMed ID: 29631209 [Abstract] [Full Text] [Related]
18. Antenatal placental assessment in the prediction of adverse pregnancy outcome after reduced fetal movement. Higgins LE, Myers JE, Sibley CP, Johnstone ED, Heazell AEP. PLoS One; 2018 Jun 02; 13(11):e0206533. PubMed ID: 30395584 [Abstract] [Full Text] [Related]
19. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study. Dutton PJ, Warrander LK, Roberts SA, Bernatavicius G, Byrd LM, Gaze D, Kroll J, Jones RL, Sibley CP, Frøen JF, Heazell AE. PLoS One; 2012 Jun 02; 7(7):e39784. PubMed ID: 22808059 [Abstract] [Full Text] [Related]